D-Wave Quantum's Bookings Surge Tells One Story — Its Income Statement Tells Another
Published on 08/12/2026 at 15:51 | Redaktion boerse-global.de
There is a widening chasm between what D-Wave Quantum is selling and what it is actually booking as revenue, and that gap has become the central tension for anyone watching the stock. The company's second-quarter results, released last Thursday, laid the divide bare: revenue of $3.08 million against analyst expectations of $4.03 million, with a GAAP net loss of $48.0 million, or $0.13 per share, versus the $0.10 consensus estimate. On the surface, that is a miss, and the market initially treated it as such.
But dig into the order book, and a very different picture emerges. Bookings for the first half of the year hit $35.5 million — a 1,120 percent surge year over year — propelled largely by a $20 million system sale to Florida Atlantic University. The company's remaining performance obligations stood at $40.7 million as of June 30, up 668 percent, with roughly 57 percent of that backlog expected to convert into recognized revenue within the next twelve months.
That disconnect between bookings momentum and reported revenue is the classic signature of a company transitioning from pilot projects to full-scale system sales. It also explains why the stock has been whipsawing: down 5.27 percent on the week, up 6.67 percent on the month, and trading at €17.87 on Wednesday with a 2.00 percent gain for the day. The twelve-month return sits at plus 12.67 percent, but the year-to-date picture is a different matter entirely — down 21.14 percent.
Wall Street's Verdict: Cautious Optimism
The analyst community has largely held its ground despite the revenue shortfall. Wedbush Securities initiated coverage on Monday with an "Outperform" rating and a $40.00 price target, pointing to D-Wave's dual-platform strategy and commercial adoption. Benchmark also launched coverage the same day with a "Buy" and a $30.00 target, citing the bookings explosion. Rosenblatt Securities reaffirmed its "Buy" rating with a $43.00 price objective.
What stands out is that even the more skeptical voices have kept their buy ratings intact, trimming price targets rather than abandoning the thesis. That suggests the underlying substance — the technology, the customer base, the pipeline — carries more weight with analysts than a single quarter's revenue volatility.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The Science Is Real, But It's Not Revenue
The technology story has been building steadily. Early this month, D-Wave published peer-reviewed research in Nature demonstrating 99.9 percent fidelity and 500-nanosecond gate times for a two-qubit gate using its dual-rail erasure qubit architecture. Forbes highlighted the paper on Friday, noting that D-Wave plans a 17-qubit demonstration as the next step. It is a legitimate milestone in fundamental research — but it is also precisely that: research, not a near-term revenue driver. The distance between a 17-qubit lab demonstration and commercially relevant systems could still be measured in years.
Commercial partnerships have been accumulating as well. AT&T expanded its existing agreement in late July to deploy D-Wave's annealing technology for network operations, including technician routing and outage detection. Nasdaq Verafin came on board in early August to explore quantum applications for financial crime detection. And the National Research Council of Canada awarded D-Wave up to CAD 300,000 to advance graph-minor embedding algorithms.
The customer mix adds another layer of credibility: commercial clients accounted for 62.4 percent of Q2 revenue, with Forbes Global 2000 companies contributing 47.7 percent. That is a meaningful shift beyond pure research contracts.
The Timing Question Nobody Can Answer
The stock sits 55.78 percent below its 52-week high of €40.41, and 60.63 percent above its 52-week low — a range that reflects just how unsettled the market remains on quantum computing valuations. The pre-market reaction to earnings was negative, but the shares have since recovered 3.9 percent, suggesting investors are weighing the bookings dynamism more heavily than the disappointing quarterly revenue.
The first half of last year, by comparison, saw a net loss of $172.8 million on higher revenue of $18.1 million. The year-over-year loss reduction is real — but it came on a weaker revenue base, which tempers the improvement considerably.
Upcoming appearances at the Needham semiconductor conference on August 20 and the Deutsche Bank technology conference in Dana Point on August 27 are unlikely to deliver fresh facts. They will more likely serve as opportunities to restate the existing narrative to investors.
The core question remains whether the bookings surge is a leading indicator of stronger quarters ahead or a reflection of lumpy, large-scale system deals that distort individual periods without establishing a sustainable pattern. The scientific advances are genuine, but they do not resolve that commercial question in the near term. The next two quarters will be the real test of whether the pipeline converts into the revenue growth the stock's story depends on.
Ad
D-Wave Quantum Stock: New Analysis - 12 August
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
